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Antibacterial agentsAbstract Since the introduction of the ﬁrst antibiotic (penicillin, 1942) into medical practice, to
date, there has been an ongoing ‘‘race’’ between scientists creating new drugs and pathogenic bac-
teria. Antibiotic-bacteria are becoming progressively common, and to make matters worse, more
and more bacteria are becoming resistant to all known antibiotics. The traditional method for this
problem is to introduce new antibiotics that kill the resistant mutants. This speciﬁc ‘‘arms race’’
resulted into thousands of potentially active chemicals are synthesized in laboratories around the
world every day.
1,3,4-Oxadiazole; 1,3,4-thiadiazole; 1,2,4-triazole and some of their derivatives are involved in
modiﬁcations at the following axes: First, attaching a thio-group into heterocyclic rings. Second,
introducing different substitutions at position 5 which often are the residuals of the synthetic start-
ing materials such as simple aliphatic, substituted aliphatic chains, aromatic carbocyclic and hetero-
cyclic residues.
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.Contents
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Deciding whether any bacterium should be considered suscep-
tible or resistant to any antimicrobial involves an integrated
assessment of in vitro activity, pharmacologic characteristics,
and clinical evaluation. Any agent approved for clinical use
has demonstrated in vitro its potential to inhibit the growththis article in press as: Othman, A.A. et al., 1,3,4-Oxadiazole, 1,3,4-thia
Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.09.003of some target group of bacteria at concentrations that can
be achieved with acceptable risks of toxicity. That is, the min-
imum inhibitory concentration (MIC) can be comfortably
exceeded by doses tolerated by the patient. Use of the antimi-
crobial in animal models and then human infections must have
also demonstrated a therapeutic response. Because the inﬂu-
ence of antimicrobials on the natural history of different cate-diazole and 1,2,4-triazole derivatives as potential antibacterial agents. Arabian
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Figure 1 Some aromatic systems of 1,3,4-oxadiazole.
1,3,4-Oxadiazole, 1,3,4-thiadiazole and 1,2,4-triazole derivatives 3gories of infection (e.g., pneumonia, meningitis, and diarrhea)
varies, extensive clinical trials must include both a range of
bacterial species and infected sites (e.g., lung, bone, CSF).
The clinical studies are important to determine whether what
should work actually does work and, if so, to deﬁne the param-
eters of success and failure. MICs must be below achievable
blood level. Clinical experience must validate in vitro data.
Once these factors are established, the routine selection of
therapy can be based on known or expected characteristics
of organisms and pharmacologic features of antimicrobial
agents. With regard to organisms, use of the term susceptible
(sensitive) implies that their MIC is at a concentration attain-
able in the blood or other appropriate body ﬂuids (e.g., urine)
using the usually recommended doses. Resistant, the converse
of susceptible implies that the MIC is not exceeded by nor-
mally attainable levels. As in all biological systems, the MIC
of some organisms lies in between the susceptible and resistant
levels. Borderline strains are called intermediate, moderately
sensitive, or moderately resistant, depending on the exact val-
ues and conventions of the reporting system. The antimicrobial
in question may still be used to treat these organisms but at
increased doses. For example, nontoxic antibiotics such as
the penicillins and cephalosporins can be administered in mas-
sive doses and may thereby inhibit some pathogens that would
normally be considered resistant in vitro. Furthermore, in uri-
nary infections, urine levels of some antimicrobial agents may
be very high, and organisms that are seemingly resistant
in vitro may be eliminated (Cole et al., 2011).
For example sulfonamides and azoles, sulfonamides are
structural analogs of para-aminobenzoic acid (PABA) and
compete with it for the enzyme (dihydropteroate synthetase),
which combines PABA and pteridine in the initial stage of
folate synthesis. This blockage has multiple effects on the bac-
terial cells; the most important of these is disruption of nucleic
acid synthesis. The effect is bacteriostatic, and the addition of
PABA to a medium that contains sulfonamide neutralizes the
inhibitory effect and allows growth to resume. When intro-
duced in the 1940s, sulfonamides had a very broad spectrum
(staphylococci, streptococci and many Gram-negative bacte-
ria), but resistance developed quickly, and this has restricted
their use for systemic infections. Now their primary use is
for uncomplicated urinary tract infections caused by members
of the Enterobacteriaceae family, particularly Escherichia coli.
Sulfonamides are convenient for this purpose because they are
inexpensive, well absorbed by the oral route, and excreted in
high levels in the urine (Shegam, 2006; Wheelis, 2007;
Dimova and Perisic-Janjic, 2009; Lindsay et al., 1994). Five
membered ring sulfonamides are closely related to azasolone
and similar related structures such as 1,3,4-oxadiazole, 1,3,4-
thiadiazole, and 1,2,4-triazoles.
A survey of literature reveals that 1,4-disubstituted thiose-
micarbazides as well as 1,3,4-oxadiazole, 1,3,4-thiadiazole,
1,2,4-triazoles and their amino derivatives are known as prom-
ising antimicrobial agents (Dimova and Perisic-Janjic, 2009;
Lindsay et al., 1994; Salgin-Goksen et al., 2007; Tehranchian
et al., 2005; Turan-Zitouni et al., 2005; Ahoya et al., 2011;
Belkadi and Othman, 2006, 2011; Khiati et al., 2007;
Benhammadi et al., 2010). Compounds of the said structure
often exhibit higher activity than standard antibiotics,
penicillin G (Salgin-Goksen et al., 2007), ampicillin and genta-
micin (Shaﬁee et al., 2002). On the other hand, various reports
reveal that the introduction of halogen atoms into thePlease cite this article in press as: Othman, A.A. et al., 1,3,4-Oxadiazole, 1,3,4-thia
Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.09.003pharmacophore structure can be beneﬁcial for antimicrobial
activity so far as this improves the lipid-solubility of the active
ingredients (Kitani et al., 1997; Tang et al., 1998).
In spite of a large number of antibiotics and chemothera-
peutics available for medical use, the antimicrobial resistance
created a substantial need for a new class of antimicrobial
agents in the last decades (Clinical and Laboratory
Standards Institute, 2006). Hydrazide hydrazones (are syn-
thetic intermediates in the synthesis of 1,3,4-oxadiazole,
1,3,4-thiadiazole, and 1,2,4-triazoles) form a class of com-
pounds possessing a wide range of biological activities viz.
antimicrobial (Baluja et al., 2007) and antimycobacterial
(Foroumadi et al., 2006).
Non-steroidal antimicrobial drugs (NSAMDs) represent a
heterogeneous family of pharmacologically active compounds.
A literature survey revealed that substances liked to 1,3,4-oxa-
diazole (Bhatia and Gupta, 2011), 1,3,4-thiadiazole (Badran
et al., 2007) and 1,2,4-triazole (Plech et al., 2011) moieties have
occupied a unique position in the design and synthesis of bio-
logically active agents with remarkable antibacterial, analgesic
and anti-inﬂammatory activities.
1. 1,3,4-oxadiazole and its derivatives
1.1. Introduction
The urgent need for new antibiotics is mainly due to the
increase in the frequency of bacterial infections with resistant
strains, especially Gram-positive organisms, in both the hospi-
tal and community settings. Oxazolidinones are a relatively
new class of antibiotics that inhibit bacterial protein synthesis
by preventing binding of the aminoacyl-tRNA to the A site of
the ribosome (Locke et al., 2010).
1,3,4-Oxadiazole (1) is a thermally stable neutral aromatic
molecule. Out of its four possible isomers 1–4, 1,3,4-oxadiazole
(1) is widely exploited for various applications (Nagaraj et al.,
2011). Other aromatic related systems are 1,3,4-oxadiazolines
(2), 1,3,4-oxadiazolium cations (3), and the exocyclic-conju-
gated mesoionic 1,3,4-oxadiazole (4) (Nagaraj et al., 2011)
(Fig. 1).
X-Linked substituents to aromatic moieties normally
appearing at positions C2, C5 and N4 may be represented by
following structural features 5–8 (Hill, 1984) (Fig. 2).
Also known are derivatives of the non-aromatic reduced
systems, 2,3-dihydro-1,3,4-oxadiazole (9), 2,5-dihydro-1,3,4-
oxadiazole (10), and 2,3,4,5-tetrahydro-1,3,4-oxadiazole (11)
(Hill, 1984) (Fig. 3).
The electronic distribution in 1,3,4-oxadiazole has been cal-
culated by versious SCF-MO methods (Kakitani and
Kakitani, 1977). Other structural parameters, dipole moment
and data to its Ultraviolet-visible (cmax calculated to be in
the region 193–203 nm), NMR, NQR and microwave spectra
have been derived. Studies on 1,3,4-oxadiazole indicate adiazole and 1,2,4-triazole derivatives as potential antibacterial agents. Arabian
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4 A.A. Othman et al.maximum positive charge in the 2-position (Ha, 1979). Molec-
ular diagrams for 1,3,4-oxadiazole, 2-phenyl- and 2,5-diphe-
nyl-1,3,4-oxadiazole, and oligomeric oxadiazoles have been
derived and conjugation between the rings is found to be sim-
ilar to that in polyphenyls (Kosobutskii et al., 1972). Calcu-
lated ionization potentials for 1,3,4-oxadiazole (1) and 1,3,4-
oxadiazoline-5-one (2, X‚O) have been compared with values
from PE spectra (Paine and Werstiuk, 1978).
1.2. Synthesis of 1,3,4-oxadiazole and derivatives
Various methods were reported in the literature for the synthe-
sis of 1,3,4-oxadiazole and its derivatives (Wang et al., 2007).
The most widely applicable route to the synthesis of 1,3,4-oxa-
diazole and its 2,5-disubstituted derivatives is the thermal, acid
and base catalyzed cyclization of their corresponding carbon-
ylhydrazides (Hill, 1984). The hydrazide prepared from car-
boxylic acid via an ester can be regarded as the real starting
material for the synthesis of 1,3,4-oxadiazole by treating the
latter with isocyanide dichlorides (Ollis and Ramsden, 1971)
(see Scheme 1).
Several carbonylhydrazide derivatives have been synthe-
sized in our laboratory starting from the appropriate carbox-
ylic acids. The common method is described by converting
the carboxylic acid to corresponding ester which on treatment
with hydrazine gives the corresponding hydrazides. The hydra-
zide derivatives (1,2-diacylhydrazines and related compounds)
are thermally on acid catalysis give 1,3,4-oxadiazole (Hill,
1984) as shown in Scheme 2.
In another way when hydrazides were treated with CS2 in
basic medium it resulted in 2-R-5-mercaptyl derivatives as
illustrated in Scheme 3 (Ollis and Ramsden, 1971; Gaetano
et al., 1991).
1.3. Tautomerism in 1,3,4-oxadiazole
2-Hydroxy (12a), 2-mercapto (12b) and 2-amino-oxadiazoles
(12c) are in equilibrium with the tautomeric oxadiazolinesRCO2H
R'OH RCO2R'
NH2NH2 RCONHNH2
O
N N
NHR'R
R'N=CCl2
Scheme 1 General synthetic method for 1,3,4-oxadiazole.
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Evidence from U.V, IR, H1-NMR and C13-NMR spectra
supports structure 13b for 1,3,4-oxadiazoline-5-thione. The
U.V and IR spectra, ﬂuorescence and pK values of 2-amino-
1,3,4-oxadiazoles indicate that the amine tautomer (12c or
12d) rather than the imine tautomer (13c or 13d) predominates
(Khiati et al., 2007).
1.4. Antibacterial activity
A variety of Mannich bases derived from 1,3,4-oxadiazole-5-
thiones show fungicidal activity and in some cases also act as
bactericides and insecticides. Various derivatives for 1,3,4-oxa-
diazole-5-thiones with R substituents distributed over posi-
tions C2,N4 and C5 were synthesized and assigned for
antibacterial activity (Ollis and Ramsden, 1971; Kumar
et al., 2011).
1.4.1. From gluconic acid
The C-nucleoside possessing 1,3,4-oxadiazolo-2-thiol (14) ring
derived from gluconic acid was found to have appreciable
effects in antibacterial activity against: Staphylococcus aureus,
Bacillus subtilis, Pseudomonas aeruginosa and E. coli using
ampicillin as standard.diazole and 1,2,4-triazole derivatives as potential antibacterial agents. Arabian
1,3,4-Oxadiazole, 1,3,4-thiadiazole and 1,2,4-triazole derivatives 5OH
O O
OO
N
O
N SH
CH3CH3
CH3CH3
14
The oxadiazole residues were found to exhibit higher
inhibition effects against these bacteria (Belkadi and Othman,
2011).
1.4.2. From salicylic acid
5-(2-Hydroxyphenyl)-1,3,4-oxadiazole-2-thione (15) has been
synthesized from salicylic acid. Antibacterial activity was
investigated in vitro against E. coli and S. aureus using ampicil-
lin and gentamycin as references.
N
O
NH
S
OH
15N N
O SHR
N N
O SR
OC2H5
O
N N
O SR
NH2
O
18 19 20
R = (a) -C 6H5 (b) -C 6H4CH3(3) (c) -C 6H4OCH 3(3) (d) -C 6H4Cl(2) (e) -C 6H4Cl(3) (f) -C 6H4Cl(4) (g) -C 5H4N(3); ; ; ; ;;The screening results indicate that the compound showed a
moderate to slight activity against other tested bacteria (Khiati
et al., 2007).
1.4.3. From pyridine carboxylic acids
5-(2-Pyridyl)-1,3,4-oxadiazole-2-thione (16) has been synthe-
sized from the corresponding 2-pyridine carboxylic acid (picol-
inic acid) and tested in vitro against the following
microorganisms: E. coli, P. aeruginosa, Enterococcus faecalis,
S. aureus, P. aeruginosa and compared with the known antibi-
otics cephalosporin and gentamycin.
N
N
O
NH
S
16
Oxadiazole derivative 16 has relatively lower inhibition
effect on S. aureus and E. coli but exhibited more effect on
P. aeruginosa (Belkadi and Othman, 2006).
1.4.4. From pyridin-2-amine
1-(5-Mercapto-1,3,4-oxadiazol-2-yl)-2-(pyridine-2-ylami-
no)ethanone (17) has been synthesized from 2-(pyridine-2-yla-
mino) acetohydrazide. This compound was found to havePlease cite this article in press as: Othman, A.A. et al., 1,3,4-Oxadiazole, 1,3,4-thia
Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.09.003signiﬁcant antimicrobial activity. The ﬁndings of the study
indicate that cyclization of the hydrazide acid group of 2-(pyr-
idine-2-ylamino) acetohydrazide into 1,3,4-oxadiazole nucleus
resulted in increased antimicrobial activity.
N NH
O
N
N
O
SH
17
The antibacterial activities of the compound 17 were tested
against some pathogenicmicroorganisms:S. aureus,Streptococ-
cus viridians and E. coli and found to have good antimicrobial
activity with higher value of MIC. From structure-activity rela-
tionships, introduction of the 1,3,4-oxadiazole ring into com-
pound signiﬁcantly increases their biological activity. The
oxadiazole ring system could be incorporated into many more
ring systems which have their own activity and could lead to
more potent and highly active compounds (Salimon et al., 2011).
1.4.5. From acylhydrazine-S-derivatives
Some novel derivatives of acylhydrazine such as; 5-substituted-
2-mercapto-1,3,4-oxadiazoles 18(a–g), their corresponding
S-esters 19(a–g) and amides 20(a–g), have been synthesized.Those compounds have been tested in vitro for their anti-
bacterial activity against E. coli bacteria by the agar well diffu-
sion method using roxithromycin and ceﬁxime as standard
drugs. The results showed that all compounds were active
against E. coli except 20f (Zareef et al., 2008).
1.4.6. From b-aroyl propionic acids
A series of 5-{3-oxo-6-(substituted aryl)-2,3,4,5-tetrahydropy-
ridazin-2-ylmethyl}-2-substituted 1,3,4-oxadiazole (21) have
been synthesized from b-aroyl propionic acids.
N N
O
R
O
N N
NH
21(a-e)
R = (a) H (b) 3,5-(CH 3)2-C6H5 (c) 4-CH 3-C6H5
(d) 4-(OC 6H5)-C6H5 (e) 4-Cl-C 6H5
; ; ;
;
All the compounds are evaluated for their antibacterial activ-
ity against E. coli, S. aureus, Micrococcus luteus and Klebsiella
pneumoniae by using the cup plate technique in the nutrient agar.
Antitubercular activity was determined using the BACTEC 460
system. All the synthesized compounds were screened against
Mycobacterium tuberculosis H37 Rv comparable with that of
standard rifampicin and isoniazid. From the results, it wasdiazole and 1,2,4-triazole derivatives as potential antibacterial agents. Arabian
6 A.A. Othman et al.observed that most of the compounds were active against the
microorganism having signiﬁcant activity against these bacteria
comparable to standard drugs, ampicillin and chloramphenicol.
The above synthesized compounds showed the percentage
inhibition ranging from 48 to 91%. Compound 21a was a
highly active analog in this series with 91% inhibition against
M. tuberculosis H37 Rv comparable with that of standard rif-
ampicin and isoniazid (Islam et al., 2008).
1.4.7. From phenylpropionohydrazides
The newly synthesized compounds 22(a–e) from phenyl propi-
onohydrazides were screened for antibacterial activity against
freshly cultured strains of S. aureus and P. aeruginosa using
ampicillin as standard.
N
O
N CH3
O
R1
R2
(a) R1 = H, R2= N(CH3)2
(b) R1 = H, R2= Cl
(c) R1 = OH, R2= OH
(d) R1 = H, R2= H
(e) R1 = H, R2= OH
22
Among newly synthesized derivatives, compounds 22(a–b)
were found to be equipotent to ampicillin when tested against
the strains of S. aureus, and P. aeruginosa, whereas some of the
newly synthesized compounds like 22a, 22d and 22e were
found to possess good antibacterial activity when tested
against S. aureus and P. aeruginosa.
After comparing the antimicrobial results of compounds
22(a–e), it was concluded that the incorporation of an oxadiaz-
ole moiety in phenylpropionyl derivatives enhances their anti-
microbial activity and also para-substitution in the R2 group of
the oxadiazoles was found to enhance their potency, especially
in compounds 22(a–b) (Fuloria et al., 2009).
1.4.8. Alkyl, alkenyl, sulfonyl, thiocarbamates and Mannich
derivatives
Alkyl, alkenyl, sulfonyl, thiocarbamates and Mannich deriva-
tives 23–26 were synthesized.
All tested compounds were assayed for their antimicrobial
activity against three standard bacterial strains, S. aureus, E.
coli and P. aeruginosa.
The lowest concentration which inhibited growth was con-
sidered as the MIC.N N
OR
1 SR2
N N
OR
1 SO2R
2
23 24
(a) R1 = 4-pyridyl ; R2 = -CH=C-CH2 R1 = Phenyl ;  R 2 = isopropyl
(b) R1 = Phenyl ; R2 = -CH=C=CH2
N N
O S
OR
O N N
OR S
N
25 26
(a) R = Benzyl R = Phenyl, 4-pyridyl
(b) R = Et
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Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.09.003The MIC for the synthesized compounds indicates that the
conversion of the sulfhydryl group in 1,3,4-oxadiazole into
alkyl 23a, allene 23b, sulfonyl 24 derivatives and mannich
product 26 showed a weak antimicrobial activity. However,
thiocarbamates 25a and 25b were effective against Gram posi-
tive and Gram negative bacteria (Muhi-eldeen et al., 2008).
1.4.9. From glucaric acid
This bis(1,3,4-oxadiazole-2-thiol) (27) derivative of glucaric acid
was essayed for antibacterial activity against S. aureus, B. subtil-
is, P. aeruginosa and E. coli using ampicillin as reference drug.
O O
OO
N
O
N SH
CH3CH3
CH3CH3
N
O
NSH
27
The oxadiazole exhibited higher inhibition effects against
these bacteria as compared with drug reference (Belkadi and
Othman, 2011).1.4.10. From terephthalic acid
5,50-benzene-1,4-diylbis(1,3,4-oxadiazole-2-thione) (28) was
synthesized from terephthalic acid and tested in vitro against
E. faecalis and E. coli and compared with known antibiotics
cephalosporin and gentamycin.
N
O
NH
S
N
O
NH
S
28
The compound showed an intermediate effect on E. faecalis
and E. coli (Datoussaid et al., 2012).1.4.11. From pyridine carboxylic acids
The bis-5-(2,6-pyridyl)-1,3,4-oxadiazole-2-thione (29) has been
synthesized from 2,5-pyridine dicarboxylic acid, and tested
in vitro against the following microorganisms: E. coli, P. aeru-
ginosa, E. faecalis, S. aureus and P. aeruginosa and compared
with the known antibiotics cephalosporin and gentamycin.
N
N
O
NH
S
O
N
NH
S
29
The results have shown that the synthesized compound 29
has very high effect in comparison to pyridine mono oxadiaz-
ole ring 16 on the gram-negative bacteria P. aeruginosa in par-
ticular, where its effect exceeded that of the well-known
cephalosporin (Benhammadi et al., 2010).diazole and 1,2,4-triazole derivatives as potential antibacterial agents. Arabian
Table 1 Effect of investigated compounds of types of
bacteria.
Compounds Gram positive bacteria Gram negative bacteria
14 + +
15 +/ +/
16 +/ +
17 + +
18 / +
19 / +
20 / +
21 + +
22 + +
23 +/ +/
24 +/ +/
25 + +
26 +/ +/
27 + +
28 +/ +/
29  +
+ Positive effect.
 Negative effect.
+/ Moderate effect.
1,3,4-Oxadiazole, 1,3,4-thiadiazole and 1,2,4-triazole derivatives 71.4.12. Conclusions
1,3,4-oxadiazoles and their thione derivatives proved to be
effective against different microorganisms as summarized in
Table 1.
2. 1,3,4-Thiadiazole and its derivatives
2.1. Introduction
1,3,4-Thiadiazoles (30) and (31) were ﬁrst described in 1882 by
Fischer and further developed by Busch. Thiadiazoles carrying
mercapto, hydroxyl and amino substituents can exist in many
tautomeric forms and this property is being intensively studied
(Kornis, 1984).
N N
S X
H
N N
S X
H
N N
S
;
30 31a 31b
1,3,4-Thiadiazoles are conveniently divided into three
subclasses:
(a) Aromatic systems which include the neutral thiadiazoles
30.R
1
C NH NH
O
C NHR
2
S
base
N
N N
H
S
R
RNH C NH NH2
S
+ HC(OR)
(a)
(b)
38 36
Scheme 5 Synthesi
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the ﬁve atoms comprising the ring.
S
N+ N
x-
R
32R
1
3
s of th
diazole(c) Non-aromatic systems such as 1,3,4-thiadiazolines (33)
and (34) and the tetrahydro-1,3,4-thiadiazolidines (35).
S
N N
H
S
N N
S
N
H
N
H
33 34 352.2. Synthesis of thiadiazoles and their derivatives
The syntheses of thiadiazoles are discussed in terms of the
number of bonds being formed and by ring transformation.
Thiadiazole synthesis by one-bond formation is exempliﬁed
by cyclization of an acylated thiosemicarbazide as shown in
Scheme 5 (Treppendahl and Jackobsen, 1977):
The synthesis of other simple mercapto-thiadiazoles is out-
lined in Scheme 6: (El-Sayed and Wasfy, 2005):
The most common two bond formation takes place via 1,3-
dipolar cycloaddition presented in Scheme 7 (Dickore and
Wegler, 1966):
1,3,4-Thiadiazoles can easily be obtained from 1,3,4-oxadi-
azoles thus in reﬂuxing 43 in ethanolic HCl rearranges to 44
(Giammanco, 1965).
O
N N
H
N S
S
N N
N OH
H+
43 44
2.3. Tautomerism
The 1,3,4-thiadiazole ring system, with three heteroatoms,
does not exhibit tautomerism in its fully conjugated form 30.
However, when certain substituents are present, tautomerism
is possible. 1,3,4-Thiadiazolin-2-ones (45a, X‚O) and -2-thi-S
N N
NHR
2
RNH C N NH2
CH(OR)3
S
N N
H
NHR
H+
37
iadiazoles.
and 1,2,4-triazole derivatives as potential antibacterial agents. Arabian
RNH C NH NH2
S
i, CS2
ii, H+ S
N N
RNH SH
36 39
Scheme 6 Synthesis of mercapto-thiadiazoles.
8 A.A. Othman et al.one (45b, X‚S) exist in the oxo and thione forms, respectively,
as shown by spectroscopic and LCAO-MO calculations.
S
N N
H
R x S
N N
R R1
45a, X=O 46
45b, X=S
2-Amino-1,3,4-thiadiazoles exist in the amino form 46
(R1‚NH2) in solution and in the solid state (Elguero et al.,
1976).2.4. Antibacterial activity
1,3,4-Thiadiazoles have activity on many biological systems.
Cefazolin (47) is a thiadiazole analog of cephalosporanic acid
useful as antibacterial (Chabbert and Lutz, 1978).
S
N
N
N N
O
NH
O
S S
N N
COOH
CH3
47
Another compound (48) is a patent as bactericidal
(Omprakash et al., 2011).
S
N N
Cl NH
O
H
48
2.4.1. From semicarbazide hydrochloride
A bioactive ligand, 2,5-diamino-1,3,4-thiadiazole (49), derived
from semicarbazide hydrochloride, and its metal complexes
were prepared and characterized (Obaleye et al., 2011).R C N NHPh
Cl
+ C C
C
EtO2C
S
N
40 41
Scheme 7 Synthesis of mercapto-thiadiazo
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N N
NH2 NH2
49
In vivo evaluation of the antimicrobial activities of the
metal complexes and the ligands showed greater activity
against some micro-organisms when compared to the parent
compounds (Obaleye et al., 2011).2.4.2. Thiadiazole phenyl oxazolidinone analogs
Replacement of the morpholine C-ring of Linezolid with a
1,3,4-thiadiazolyl ring leads to oxazolidinone analogs 50(a–d)
having potent antibacterial activity against both gram-positive
and gram-negative organisms.
N
O
S
NN
NH
R
F
O
NH S
CH3
50(a-d)
R= (a) H; (b) CH3SO2CH2 ; (c) H2NCH2 ; (d) CH3NHCH2
All of the analogs 50(a–d) were tested in vitro against a
panel of gram-positive and fastidious gram-negative bacteria.
Selected compounds were also evaluated for in vivo effect
against S. aureus in a mouse bacteremia model. All of these
analogs exhibited good to excellent antibacterial activity,
including good activity against fastidious gram-negative
organisms. In many cases, the compounds had superior activ-
ity to linezolid. The in vitro activity of the 1,3,4-thiadiazolyl
phenyl oxazolidinones is relatively insensitive to the nature
of the substituent at the 2-position. As expected, the thioaceta-
mide analogs 50(a–d) are extremely potent against both gram-
positive and fastidious gram-negative organisms. Various
1,3,4-thiadiazole analogs had in vivo activity comparable to lin-
ezolid, but the thioamides lacked oral activity presumably due
to metabolism of the thioamide.
Oxazolidinone analogs that contain a 1,3,4-thiadiazole C-
ring represent a new class of oxazolidinone antibacterial agents
having excellent activity against both gram-positive and fastid-
ious gram-negative organisms.
1,3,4-Thiadiazolyl phenyl oxazolidinones are useful exten-
sions of the quantitative structure-activity relationship of the
oxazolidinone class of antibacterial agents (Thomasco et al.,
2003).S
N N
RC
C
EtO2C
Ph
N
42
les by 1,3-dipolar cycloaddition reaction.
diazole and 1,2,4-triazole derivatives as potential antibacterial agents. Arabian
1,3,4-Oxadiazole, 1,3,4-thiadiazole and 1,2,4-triazole derivatives 92.4.3. Sulfonyl-1,3,4-thiadiazoles derivatives
Bahram et al. reported the synthesis and antibacterial activity
of a new series of 2-(1-methyl-4-nitro-1H-imidazol-5-ylsulfo-
nyl)-1,3,4-thiadiazoles 51(a–c) (Bahram et al., 2011). The three
compounds were tested in vitro by the conventional agar dilu-
tion method against a panel of microorganisms including
gram-negative and gram-positive bacteria.
S
N N
RS
S
O O
N
N
NO2
CH3
51(a-c)
R = N
N
CH3O2N
CH3
O CH3O2N(a) CH3CONH- ; (b) ; (c) 
Compound 51c with 5-(5-nitrofuran-2-yl)-residue on 1,3,4-
thiadiazole scaffold had shown promising antibacterial activi-
ties against gram-positive bacteria including S. aureus, Staph-
ylococcus epidermidis and B. subtilis (Bahram et al., 2011).2.4.4. Newly synthesized cephalosporins
New arylideneamino-(1,3,4-thiadiazol-5-yl)-dithioacetamido-
cephalosporanic acids 52(a–d) have been synthesized and tested
in vitro antimicrobial activities of the prepared cephalosporins
were investigated using a panel of selected microorganisms.
The antimicrobial activities of the newly synthesized ceph-
alosporins as in compounds 52(a–d) were determined by the
agar diffusion method using representative Gram (+) and
Gram () bacteria on tryptic soya agar media.
The test microorganisms used to evaluate the potential anti-
microbial activity of the newly synthesized cephalosporins
were: S. aureus, E. coli, P. aeruginosa and M. luteus. Cepha-
lexin was used as a reference.
S
N
COOH
O CH3
O
O
NH
O
S
S
S
N
N
N
R
52(a-d)
R = (a) H ; (b) Cl ; (c) Br ; (d) NO2
Cephalosporins containing 1,3,4-thiadiazole moiety linked
through a disulﬁde bond in the acyl side chain compounds
52(a–d) were the most potent and were found to be equipotent
to cephalexin, especially compounds 52c and 52d. This ﬁnding
was expected and was supported when compared with antibi-
otics containing disulﬁde bonds which showed marked activi-
ties (Alwan, 2012).Please cite this article in press as: Othman, A.A. et al., 1,3,4-Oxadiazole, 1,3,4-thia
Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.09.0032.4.5. From 6-methyl-1,3-benzothiazol-2-amine
A series of 2-aryl-5-(60-chloro-10,30-benzothoazole-2-yl-
amino)-1,3,4-thiadiazoles 53(a–j) have been synthesized from
6-methyl-1,3-benzothiazol-2-amine and screened for both anti-
bacterial activities using oﬂoxacin as a standard drug. The
compounds were screened against S. aureus, E. coli and P.
aeruginosa in nutrient agar medium.
Cl
N
S
NH
N
N
S
R
53(a-j)
R = (a) phenyl ; (b) 4-chlorophenyl ; (c) 2,4-dichlorophenyl ; 
(d) 4-nitrophenyl ; (e) 2-aminophenyl ;
(f) 2,4-dichlorophenoxymethyl ; (g) 2-naphthylmethyl ; 
(h) 4-methoxyphenyl ; (i) 2-acetoxyphenyl ; (j) 3-pyridyl
The thiadiazole derivative 53i having an acetoxy-phenyl
group showed potent activity against S. aureus, whereas com-
pound 53g having the 2-napthyl-methyl group showed maxi-
mum inhibition against E. coli, when compared with
standard drug oﬂoxacin. Compound 53c having the 2,4-
dichloro-phenyl group also showed signiﬁcant antibacterial
activity against S. aureus, E. coli and P. aeruginosa. Rest of
the compounds showed moderate to good antibacterial activity
(Amir et al., 2009).2.4.6. Derivatives of 5-amino-2-hydroxybenzoic acid
Variously substituted 4-amino-2-{5-[(4-substituted phenyl)a-
mino]-1,3,4-thiadiazole-2-yl} phenol 54(a–g) were synthesized
and evaluated for their antibacterial activity.
NH2
OH
N
S
N
NH
R
(54a-g)
R = CH3
CH3
CH3
OMe Cl
Cl
F BrF
(a) (b) (c) (d)
(e) (f) (g)
These compounds showed signiﬁcant antibacterial activity
against S. aureus and E. coli bacteria using the cup plate tech-
nique (Hussain et al., 2008).2.4.7. Conclusions
1,3,4-Thiadiazole and its derivatives proved to be effective
against different microorganisms as summarized in Table 2.
3. 1,2,4-Triazole and its derivatives
3.1. Introduction
Triazoles are two basic aromatic heterocycle isomers, 1,2,3-tri-
azole (55) and its isomer 1,2,4-triazole (56).diazole and 1,2,4-triazole derivatives as potential antibacterial agents. Arabian
Table 2 Effect of investigated compounds of types of
bacteria.
Compounds Gram positive bacteria Gram negative bacteria
47 + +
48 + +
49 + +
50 + +
51 + 
52 + +
53 + +
54 + +
+ Positive effect.
 Negative effect.
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N
H
N
N
N
H
55 56
1,2,4-Triazole derivatives ﬁnd uses in a wide variety of
applications mostly antifungals such as ﬂuconazole and
intraconazole. 4-Amino-5-mercapto-3-substituted-1,2,4-tria-
zole showed antifungal, anti-inﬂammatory and antitubercular
properties that have made them important chemotherapeutic
agents (Kurtzer et al., 1965). Some 3,6-disubstituted-1,2,4-tria-
zol[3,4-b]-1,2,4-thiadiazole derivatives (57) showed anti HIV-1
activity at concentrations slightly below cytotoxic levels.
S
N
N
N
N
Me
R
57
Partially or fully reduced triazoles (thiazolines and thiazol-
idine respectively) with monovalent substituents are respec-
tively unstable and of little interest. Triazolines and
thiazolidines with exocyclic bonds such as‚O,‚S,‚NR0R00,
‚CR0R00, etc. are also aromatic (Polya, 1984).
Substituents to aromatic and non-aromatic 1,2,4-triazoles
can be situated in all positions of the molecule due to multiple
valency of carbon and nitrogen atoms.
Bridgehead nitrogen-heterocyclic compounds obtained by
fusion of the 4,5-dihydroimidazole and [1,2,4]triazole nuclei,
have identiﬁed one compound containing the methylthio
group at position 3 and with a 4-methylphenyl substituent at
position 7 (e.g., 7-(4-methylphenyl)-3-methylthio-5H-6,7-dihy-
droimidazo[2,1-c][1,2,4]triazole) with a signiﬁcant antibacterial
activity. This heterocycle was strongly active against S. aureus
and showed superior antibacterial activity to ampicillin
(Sztanke et al., 2006).
1,2,4-Triazole and its amino derivatives, tetrazole, thiadia-
zole, pyrazole, imidazole and the corresponding derivatives
have been studied as corrosion inhibitors of copper based
material such as bronzes (Khiati et al., 2011).
1,2,4-Triazole (56) may exist in equilibrium between three
forms: 1H-form(i), 1H-form(ii) and 4H-form as following,
N N
N
H
N N
N
H
N N
N
H 1 1 12 2 2
3 3 3
4 4
4
5 5 5
1H-form(i) 1H-form(ii)   4H-form
The calculated energy differences between azole tautomers
support preference for the 1Hover 4H tautomer. Similarly,
the usual tautomeric preference for triazolines over hydroxy-
triazoles and aminotriazoles over triazolinimines is supported
on thermochemical evidence (Dewar and Morita, 1969).
The molecular structure of 1,2,4-triazole (56) was deter-
mined by gas phase electron diffraction. The internuclear dis-
tances and bond angles were obtained by applying a least-
squares analysis to the experimental intensity. The bond dis-
tances (rg) and bond angles suggested that the 1,2,4-triazole
exists in an 1H-form. The bond distances N1–N2 =Please cite this article in press as: Othman, A.A. et al., 1,3,4-Oxadiazole, 1,3,4-thia
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0.009 A˚, N1–C5= 1.377 ± 0.004 A˚, N4=C5= 1.305 A˚ (calcu-
lated value), N1–H= 0.990 A˚, C3–H and C5–H= 1.054 A˚. The
bond angles \N1N2C3= 102.7 ± 0.5, \N2C3N4= 113.8 ±
01.3, \N2N1C5= 108.9 ± 0.8, \H1N1N2= 110.9,
\H2C3N4= 119.2, \H3C5N1= 121.0, \C3N4C5= 105.7
(calculated value), and \N4C5N1= 108.7 (calculated value).
Whereas the substituted C3-S-preferred the 4H-form based
on the crystal structure of 4H-1,2,4-triazole-3-mercapto acetic
acid (58) which showed that atoms C3,C5,N1,N2,N4 are
coplanar and form a conjugated plane with a mean deviation
of 0.002 A˚.
N N
N
H
S
O
OH
1 2
3
4
5
58
The bond lengths of C3-N2, C3-N4, C5-N4, C5-N1 and
N1-N2 are 1.317(2) A˚, 1.364(2) A˚, 1.328(2) A˚, 1.317(2) A˚,
and 1.362 A˚ respectively, being in accordance with 4H-form
(Chiang and Lu, 1977).
3.2. Synthesis of 1,2,4-triazoles and their derivatives
During the last few decades, considerable attention has been
paid to synthesize 1,2,4-triazole derivatives possessing compre-
hensive bioactivities as antibacterial and antimycobacterial
(Klimesova´ et al., 2004).
Several methods for the synthesis of 1,2,4-triazole and its
derivatives were reported (Zaharia et al., 2001). One of these
methods follows cyclization of aminoacylhydrazines (60) and
acyl halides as shown in Scheme 8. Sometimes this method
may be used into formation of some 1,3,4-oxadiazole deriva-
tives (61,62) (Gehlen and Blankenstein, 1960).
The most common procedure to synthesize the 1,2,4-triazole-
5-thiol derivatives (64) is also involving a base catalyzed cycliza-
tion of thiosemicarbazides (63) or its thio derivative as shown in
Scheme 9 (Wheelis, 2007; Zhang et al., 2002) (see Scheme 10).
3.3. Antibacterial activity
It has been shown that the antiviral and antibacterial activities
of thiourea derivatives are due to the presence of the –NH–
C(S)–NH– function in the molecule and that changes in thisdiazole and 1,2,4-triazole derivatives as potential antibacterial agents. Arabian
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et al., 2001). Thus, the substitute groups present in vari-
ous compounds have different effects against different
bacteria.
Regarding antimicrobial activity, triazole is structurally
similar to imidazole molecule. Although triazole and imidazole
act by the same mechanism of action, triazoles possess advan-
tages over imidazoles, which have slow metabolic rate, oral
bioavailability, and less effect on human sterol synthesis. For
these reasons imidazoles are slowly being replaced by triazole
molecules (Palekar et al., 2009).
3.3.1. From gluconic acid
New acyclo C-nucleosides bearing 1,2,4-triazole-3-thiol
(65)moieties derived from gluconic acid were synthesized and
tested against S. aureus, E. faecalis, P. aeruginosa and E. coli
using ampicillin as standard.
OH
O O
OO
NH
N
N SH
CH3CH3
CH3CH3
65
The triazole exhibited weaker inhibition effects than ampi-
cillin against these bacteria (Belkadi and Othman, 2011).
3.3.2. From salicylic acid
3-(2-hydroxyphenyl)-1H-1,2,4-triazol-5-thiol (66) has been
synthesized starting from salicylic acid and tested in vitro
against E. coli, P. aeruginosa and S. aureus using ampicillin
and gentamycin as references.N N
N X
3X5
H
H R
N N
NX
RH
H
N N
N X
3X5
H R
H
X
H
X3, X5 = O,S or N
Scheme 8 Tautomeric structure
N
N
NHR''
NH
R'
R''+X C
NHNHR'
NH2
59 60
Scheme 9 Synthesis
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H
N
N
SH
OH
66
The screening results indicate that the compound 66
showed a moderately active effect against all bacteria tested
(Khiati et al., 2007).
3.3.3. From substituted aniline
Hussain et al. synthesized a series of 1-[(1,2,4-triazole-4-yl) car-
bothioamide]-3,5-dimethyl-4-[(substituted phenyl) diazenyl]
pyrazoles 67(a–d). These compounds were investigated for
their antibacterial activities.
N
N
N
N
CH3
CH3
NH
S
N
NN
R
67(a-d)
R: (a) m-Cl, p-F ; (b) p-SO2NH2 ; (d) m-COOH, p-OH 
N
NH
CH3
CH3
SO2; (c) p
Antibacterial activities of the synthesized compounds were
determined in vitro against S. aureus and E. coli. Standard anti-
biotic oﬂoxacin was used as reference drug.
These compounds showed moderate antimicrobial activity
against tested bacterial strains (Hussain et al., 2010).N N
NX
R
N N
N X
35
H
R
N N
N X
3X5
R
H
H
R'
etc
s of substituted 1,2,4-triazole.
X
N N
NH2R''
R' =HC Halogen
O
61, X=NR’;62,X=O,S
of 1,2,4-triazole.
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Scheme 10 Synthesis of 1,2,4-triazole-5-thiole.
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This bis(1,2,4-triazole-3-thiol) (68) derivative of glucaric acid
was essayed for antibacterial activity against P. aeruginosa
and E. coli using ampicillin as reference drug.
O O
OO
NH
N
N SH
CH3CH3
CH3CH3
NH
N
NSH
68
The triazole exhibited an important antibacterial activity
against these bacteria (Belkadi and Othman, 2011).
3.3.5. From terephthalic acid
5,50-Benzene-1,4-diylbis(1H-1,2,4-triazole-3-thiol) (69a) and its
derivatives 69(b-c) were synthesized from terephthalic acid and
tested in vitro against P. aeruginosa and E. coli and compared
with known antibiotics cephalosporin and gentamycin.
N
N
N
S
N
N
N
S
R2
R1
R2
R1
69(a-c)
(a) : R1 = R2 = H (b) : R1 = H , R2 = CH3 (c) : R1 = R2 = CH3; ;
Triazole 69a exhibited an intermediate effect on P. aerugin-
osa while methyl triazole 69b showed a similar effect on the
same bacteria. The highest effect was observed by dimethyl tri-
azole 69c upon E. coli at the lowest concentration (Datoussaid
et al., 2012).
3.3.6. Conclusions
1,2,4-Triazole and its derivatives proved to be effective against
different microorganisms as summarized in Table 3.
4. C–R and N–R derivatives of 1,2,4-triazol-5-thiol
4.1. Introduction
Three categories of derivatives may be observed for 1,2,4-tria-
zoles. The ﬁrst category is the C–R derivatives, they existed in
two types, either C3–R or C5–R and C3–R and C5–R deriva-
tives. The second category involves Cx–R and Ny–R deriva-
tives. The third category involves N1–R derivatives, N2–R
derivatives and N1 and N2 derivatives. The C3–R or C5–RPlease cite this article in press as: Othman, A.A. et al., 1,3,4-Oxadiazole, 1,3,4-thia
Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.09.003and C3–R and C5-R derivatives may be chosen from the
beginning of the synthesis by selecting the appropriate starting
material such as the wanted carboxylic acid.
4.2. Synthesis
The Nx–R derivatives were either made up by substitution on
N– atom or by selecting the appropriate hydrazine derivatives.
The 71, N4–R and 72, N4–NH2 can be derived from reaction of
1,3,4-oxadiazoles (70) with R3NH2 or NH2NH2 respectively
(Palekar et al., 2009) (see Scheme 11).
Another method for preparation of N–NH2 derivative is by
treating the triazoles with methyl iodide.
4.3. Antibacterial activity
4.3.1. From sodium salt of a-sulphonated fatty acid hydrazide
Sodium 1-[4-amino-5-mercapto-4H-(1,2,4)triazol-3-yl]hepta-
decane-1-sulfonate (73) has been synthesized.
N
NN
NH2
SH
SO3Na
(CH2)15 CH3
73
The antibacterial activity of the compound was determined
in vitro against various pathogenic bacteria such as gram posi-
tive bacteria (B. subtilis, S. aureus) and gram negative bacteria
(E. coli). The results indicated that the compound was highly
active against selected pathogens (El-Sayed, 2006).
4.3.2. From gluconic acid
An acyclo C-nucleoside bearing 4-amino-1,2,4-triazole-3-thiol
moieties (74) derived from gluconic acid was synthesized and
tested against S. aureus, and E. coli using ampicillin as
standard.
OH
O O
OO
N
N
N SH
CH3CH3
CH3CH3
NH2
74
The activity of the compound is equal to that of ampicillin
in terms of antibacterial activity against S. aureus. The com-
pound 74 has a moderately active effect on E. coli bacteria
(Belkadi and Othman, 2011).diazole and 1,2,4-triazole derivatives as potential antibacterial agents. Arabian
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Scheme 11 Synthesis of 71, N4–R and 72, N4–NH2 from
Table 3 Effect of investigated compounds of types of
bacteria.
Compounds Gram positive bacteria Gram negative bacteria
65 +/ +/
66 +/ +/
67 +/ +/
68 / +
69 / +
+ Positive effect.
+/ Moderate effect.
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3-(2-Hydroxyphenyl)-4-amino-1,2,4-triazol-5-thiol (75) has
been synthesized starting from salicylic acid and tested
in vitro against E. coli and S. aureus using ampicillin and gen-
tamycin as references.
N
N
N
SH
OH NH2
75
The screening results indicate that the compound showed a
moderate to slight activity against bacteria tested (Khiati et al.,
2007).
4.3.4. From glucaric acid
The bis (4-amino-1,2,4-triazole-3-thiol) (76) derivative of gluc-
aric acid was essayed for antibacterial activity against P. aeru-
ginosa and E. coli using ampicillin as reference drug.
O O
OO
NH
N
N SH
CH3CH3
CH3CH3
NH
N
NSH
76
The bis-amino-triazole 76 exhibited an important antibacte-
rial activity against these bacteria (Belkadi and Othman, 2011).4.3.5. From isoniazid
Synthesized 5-substituted-3-pyridine-1,2,4-triazole 77(a–g) has
been tested for antibacterial activity.
N
N
N N
NH2
R
77(a-g)
R = (a) C6H5- ; (b) 4-C2H4-C6H4- ; (c) 4-NH2-C6H4- ; (d) 2-OH-C6H4- ;
(e) 2-NH2-C6H4- ; (f) 4-OH-C6H4- ; (g) 4-CH3-C6H4-Please cite this article in press as: Othman, A.A. et al., 1,3,4-Oxadiazole, 1,3,4-thia
Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.09.003A cup plate method was employed for the in vitro study of
antibacterial effect against B. subtilis, S. aureus, Proteus mira-
bilis and Salmonella typhi.
The screening result indicates that all compounds exhibited
moderate to good antibacterial activities. It was reported that
compounds with free NH2 in the 4th position C 77(a–g)
showed inhibitory effect against one or more types of bacteria
and also due to the presence of the triazole ring system in the
synthesized compounds, that exhibited antimicrobial activity.
Compounds 77(b–d) showed moderate antibacterial activity.
Among the synthesized compounds, compound 77f showed
good antibacterial activity (Muthal et al., 2010).
4.3.6. Triazole containing Thiophene moieties
Some 3-(thenylmethyl)-4-substituted-4,5-dihydro-1H-1,2,4-
triazol-5-one 78(a–e) derivatives were synthesized by the cycli-
zation reaction of 1-(thiophen-2-ylacetyl)-4-substituted semi-
carbazide derivatives and were evaluated in vitro against
several species of aerobic bacteria.
S N
N
NH
OR
78(a-e)
R = (a) C6H5 ; (b) C2H5 ; (c) 4-CH3C6H4 ; (d) 4-BrC6H4 ;  (e) C6H11
Some of them showed activity against K. pneumoniae, S.
aureus, Streptococcus pyogenes and P. aeruginosa. Among
tested compounds, the most effective was 78c. The highest sus-
ceptibility to tested derivative was detected in S. pyogenes, P.
aeruginosa and S. aureus (Pitucha et al., 2010).
4.3.7. Triazole, amino triazole and thiadiazole derivatives of 5-
Amino-2-hydroxybenzoic acid
4-amino-2-[4-(4-methylphenyl)-5-sulfanyl-4H-1,2,4-triazol-3-
yl]phenol (79), 4-amino-2-{4-amino-5-[(4-chlorophenyl)amino]-
4H-1,2,4-triazol-3-yl}phenol (80) and 4-amino-2-{5-[(4-substi-
tuted phenyl)amino]-1,3,4-thiadiazole-2-yl} phenol (81a–c) were
synthesized and evaluated for their antibacterial activity against
bacterial strain S. aureus and E. coli. Oﬂoxacin was used as stan-
dard drugs.
NH2
OH
N
N
NSH
CH3
NH2
OH
N
N
N
NH
NH2
Cl
79 80
oxadiazoles 70.diazole and 1,2,4-triazole derivatives as potential antibacterial agents. Arabian
Table 4 Effect of investigated compounds of types of
bacteria.
Compounds Gram positive bacteria Gram negative bacteria
73 + +
74 + +/
75 +/ +/
76 / +
77 + +
78 + +
79 + +
80 + +
81 + +
+ Positive effect.
+/ Moderate effect.
14 A.A. Othman et al.Compounds 79 and 80 showed signiﬁcant antibacterial
activity against S. aureus (gram-positive) and E. coli (gram-
negative) bacteria using the cup plate technique.
NH2
OH
N
S
N
N
H
R1
R2
(a) R1 = F ; R2 = Cl 
(b) R1 = Cl; R2 = H 
(c) R1 = F; R2 = H 
81(a-c)
The 5-amino-2-hydroxybenzohydrazide derivative (81a)
having the 3-chloro-4-ﬂuorophenyl amino group at the 2nd
position of the thiadiazole ring was found to have MIC
25 lg/mL against S. aureus and E. coli. 1,3,4-thiadiazole deriv-
atives 81b and 81c also exhibited promising antibacterial activ-
ity (MIC 25 lg/mL) against S. aureus (Hussain et al., 2008).4.3.8. Conclusions
C–R and N–R derivatives of 1,2,4-triazol-5-thiol proved to be
effective against different microorganisms as summarized in
Table 4.
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